Regulatory22 Oct 2026 · Wed night
ALKEMAlkem Laboratories
Alkem appoints Grant Thornton for forensic audit of alleged employee fund misappropriation
Alkem Laboratories' audit committee approved an independent forensic investigation into alleged misappropriation of funds by a former employee, linked to procurement transactions.
Price, Wednesday's close₹5,015.00▲ 0.22%
Last 5 days
52-week low ₹4,891.5052-week high ₹5,933.50
- Sector
- Pharmaceuticals
What happened
- The audit committee approved the appointment of Grant Thornton Bharat LLP on 21 October to investigate alleged fund misappropriation by a former employee, according to Whalesbook and Sahi.
- Sahi said the work covers historical procurement transactions and root causes, starting with a preliminary review of electronically stored information and market intelligence.
- Neither report gave an amount, the former employee's role or any financial impact. Whalesbook published at 9:50 PM on Wednesday and Sahi at 6:03 AM on Thursday.
- The shares closed at ₹5,015 on Wednesday, per Zerodha Kite, before the disclosure.
Why it matters
The scale of any loss has not been disclosed, so the size of the matter is not yet known from the reports.
Good to know: A forensic audit is an investigation that traces transactions to establish what happened, who was involved and how much money is affected. It is separate from the routine statutory audit.
Key facts
- Investigator
- Grant Thornton Bharat LLP
- Approved by
- Audit committee, 21 October 2026
- Amount involved
- Not disclosed in either report
Read the source
This is a summary of public news about Alkem Laboratories, for information only. It is not a recommendation to buy, sell or hold ALKEM.